BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6301262)

  • 1. Effect of ranitidine on healing of peptic ulcer: a 2-month study.
    Leroux P; Farley A; Archambault A; Pilon G; Gosselin D; Paré P; Lévesque D; Sherbaniuk R; Thomson AB
    Am J Gastroenterol; 1983 Apr; 78(4):227-30. PubMed ID: 6301262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative trial of ranitidine 300 mg at night with ranitidine 150 mg twice daily in the treatment of duodenal and gastric ulcer.
    Farley A; Lévesque D; Paré P; Thomson AB; Sherbaniuk R; Archambault A; Mahoney K
    Am J Gastroenterol; 1985 Sep; 80(9):665-8. PubMed ID: 3898818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of duodenal and gastric ulcer with ranitidine--a controlled, multicentre clinical trial.
    Gibinski K; Nowak A; Gabryelewicz A; Szalaj W; Hasik J; Klincewicz H; Pokora J; Radwan P; Kosecki P; Pachlewski J
    Dtsch Z Verdau Stoffwechselkr; 1982; 42(2-3):64-9. PubMed ID: 6286274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentre double blind clinical trial on ranitidine for gastroduodenal ulcer.
    Gibinski K; Nowak A; Gabryelewicz A; Szalaj W; Hasik J; Klincewicz H; Pokora J; Radwan P; Kosecki P; Pachlewski J
    Hepatogastroenterology; 1981 Aug; 28(4):216-7. PubMed ID: 6115807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo controlled studies with ranitidine in duodenal ulcer.
    Dobrilla G; Barbara L; Bianchi Porro G; Felder M; Mazzacca G; Miglioli L; Pera A; Petrillo M; Sabbatini F; Verme G
    Scand J Gastroenterol Suppl; 1981 Jun; 69():101-7. PubMed ID: 6119771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind endoscopically controlled trial of ranitidine in a high incidence area.
    Moshal MG; Spitaels JM; Khan F
    Scand J Gastroenterol Suppl; 1981 Jun; 69():129-31. PubMed ID: 6119777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranitidine in the treatment of gastric, prepyloric and duodenal ulcer--a controlled prospective double-blind trial.
    Darle N; Almskog B; Falk A; Fredriksen B; Gamklou R; Ivarsson L; Karlström L
    Ann Clin Res; 1984; 16(1):6-9. PubMed ID: 6331270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranitidine in the treatment of peptic ulcer.
    Makalinao AU; Zaño FM
    Clin Ther; 1984; 6(2):185-92. PubMed ID: 6322992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early evening ranitidine administration promotes faster duodenal ulcer healing.
    Merki H; Witzel L; Hüttemann W; Ansari A; Panijel M; Harre K; Heim J; Wolbergs E; Neumann HJ; Röhmel J
    Am J Gastroenterol; 1988 Apr; 83(4):362-4. PubMed ID: 3279756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic double-blind controlled trial of ranitidine vs placebo in the short-term treatment of duodenal ulcer.
    Dobrilla G; de Pretis G; Felder M; Chilovi F
    Hepatogastroenterology; 1981 Feb; 28(1):49-52. PubMed ID: 6111528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
    Lanza F; Goff J; Scowcroft C; Jennings D; Greski-Rose P
    Am J Gastroenterol; 1994 Aug; 89(8):1191-200. PubMed ID: 8053433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranitidine: a pilot study in Japan.
    Takemoto T; Okazaki Y; Okita K; Namiki M; Ishikawa M; Oshiba S; Kurokawa K
    Scand J Gastroenterol Suppl; 1981 Jun; 69():125-8. PubMed ID: 6119776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
    Campbell DR; Haber MM; Sheldon E; Collis C; Lukasik N; Huang B; Goldstein JL
    Am J Gastroenterol; 2002 Sep; 97(9):2208-14. PubMed ID: 12358234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled trial with ranitidine in the treatment of peptic ulcer.
    Nelis GF
    Neth J Med; 1981; 24(6):224-8. PubMed ID: 6119631
    [No Abstract]   [Full Text] [Related]  

  • 16. Ranitidine 300 mg at bedtime is effective for gastric ulcers: a 12-wk, multicenter, randomized, double-blind, placebo-controlled comparison. The Ranitidine 300 mg HS Gastric Ulcer Study Group.
    Johnson JA; Euler AR; Northcutt AR; McSorley DJ
    Am J Gastroenterol; 1993 Jul; 88(7):1071-5. PubMed ID: 8317408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
    Bardhan KD; Wurzer H; Marcelino M; Jahnsen J; Lotay N; Roberts PM
    Am J Gastroenterol; 1998 Mar; 93(3):380-5. PubMed ID: 9517644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
    Russo A; Dattilo M
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of ranitidine maintenance treatment of duodenal ulcer.
    Boyd EJ; Wilson JA; Wormsley KG
    Scand J Gastroenterol; 1984 May; 19(3):394-400. PubMed ID: 6330871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranitidine: a new H2-receptor antagonist.
    Berner BD; Conner CS; Sawyer DR; Siepler JK
    Clin Pharm; 1982; 1(6):499-509. PubMed ID: 6309467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.